SEC Form 4 · accession 0001225208-16-027214
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Malone
Officer — Vice President & Controller
Period of report
Feb 19, 2016
Accepted (ET)
Feb 22, 2016 · 3:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 19, 2016 | F | 205 | $59.21 | D | 22,466 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.